Virtual Radiologic
(vRad), a technology-enabled national radiology practice, has announced a premier radiology partnership with
ICON Medical Imaging
(ICON), the medical imaging division of ICON plc.
ICON Medical Imaging provides medical imaging-based product development services to the pharmaceutical biotechnology and medical device industries. The partnership with vRad will enable ICON Medical Imaging to access the breadth and depth of vRad's subspecialty expertise and to obtain high-quality interpretations provided by vRad's fellowship-trained radiologists.
The first clinical trial involving vRad launched in September, with more expected to rapidly follow. This partnership will provide a great opportunity for vRad radiologists to make an impact on advancing healthcare. The use of imaging in clinical trials has been recognized by the pharmaceutical industry to assist in measuring early results, thereby helping to shorten the timeline for bringing effective drugs to market, and saving costs and lives in the process.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.